Clinical Trial Update: Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination [Phase 1]

View source ↗

Summary

Phase I study of irinotecan, 5-fluorouracil, and leucovorin in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Camptosar) (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Metastatic, Colorectal | Phase 1 | Status: COMPLETED